Clinical Trials Browser

Phase 1 × Practice Guidelines as Topic × 30 days × Clear all

NCT07025538 2026-04-20

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Phase 1 Recruiting

Hematopoietic and Lymphatic System Neoplasm

NCT03922035 2026-04-07

CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Phase 1 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms